CME icon

CME Group

261.85 USD
-0.87
0.33%
At close Mar 27, 4:00 PM EDT
After hours
261.65
-0.20
0.08%
1 day
-0.33%
5 days
-1.74%
1 month
4.80%
3 months
12.14%
6 months
19.95%
Year to date
12.52%
1 year
21.45%
5 years
52.82%
10 years
176.62%
 

About: Based in Chicago, CME Group operates exchanges giving investors, suppliers, and businesses the ability to trade futures and derivatives based on interest rates, equity indexes, foreign currencies, energy, metals, and commodities. The Chicago Mercantile Exchange was founded in 1898 and in 2002 completed its IPO. Since then, CME Group has consolidated parts of the industry by merging with crosstown rival CBOT Holdings in 2007 before acquiring Nymex Holdings in 2008 and NEX in 2018. In addition, the company has a 27% stake in S&P Dow Jones Indices, making the Chicago Mercantile Exchange the exclusive venue to trade and clear S&P futures contracts. Through CME's acquisition of NEX, it also expanded into cash foreign exchange, fixed-income trading, and collateral optimization.

Employees: 3,760

0
Funds holding %
of 7,390 funds
0
Analysts bullish %
of 9 analysts

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

159% more first-time investments, than exits

New positions opened: 189 | Existing positions closed: 73

53% more call options, than puts

Call options by funds: $492M | Put options by funds: $322M

41% more funds holding in top 10

Funds holding in top 10: 37 [Q3] → 52 (+15) [Q4]

20% more repeat investments, than reductions

Existing positions increased: 580 | Existing positions reduced: 484

6% more funds holding

Funds holding: 1,370 [Q3] → 1,455 (+85) [Q4]

6% more capital invested

Capital invested by funds: $70.5B [Q3] → $74.6B (+$4.1B) [Q4]

0.48% less ownership

Funds ownership: 88.78% [Q3] → 88.31% (-0.48%) [Q4]

Research analyst outlook

9 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$212
19%
downside
Avg. target
$259
1%
downside
High target
$287
10%
upside

9 analyst ratings

positive
33%
neutral
56%
negative
11%
Raymond James
Patrick O'Shaughnessy
72% 1-year accuracy
13 / 18 met price target
10%upside
$287
Outperform
Upgraded
10 Mar 2025
Morgan Stanley
Mike Cyprys
57% 1-year accuracy
4 / 7 met price target
0%upside
$263
Equal-Weight
Maintained
19 Feb 2025
Keefe, Bruyette & Woods
Kyle Voigt
77% 1-year accuracy
24 / 31 met price target
2%downside
$257
Market Perform
Maintained
14 Feb 2025
RBC Capital
Ashish Sabadra
75% 1-year accuracy
39 / 52 met price target
3%upside
$269
Sector Perform
Maintained
13 Feb 2025
Oppenheimer
Owen Lau
63% 1-year accuracy
32 / 51 met price target
3%upside
$269
Outperform
Maintained
13 Feb 2025

Financial journalist opinion

Based on 29 articles about CME published over the past 30 days

Positive
Zacks Investment Research
6 hours ago
Are You Looking for a Top Momentum Pick? Why CME Group (CME) is a Great Choice
Does CME Group (CME) have what it takes to be a top stock pick for momentum investors? Let's find out.
Are You Looking for a Top Momentum Pick? Why CME Group (CME) is a Great Choice
Neutral
Zacks Investment Research
9 hours ago
Forget Tech: Buy These 5 Non-Tech High Flyers of Q1
Here we discuss five non-tech stocks that have provided double-digit returns year to date, defying the negative trends of U.S. stock markets. These are TPR, WEC, CNP, CME and CEH.
Forget Tech: Buy These 5 Non-Tech High Flyers of Q1
Positive
Seeking Alpha
10 hours ago
CME Group At A New All-Time High - Valuation Concerns Justified?
CME shares have delivered market-beating returns over the past two years, prompting the question of whether it's time to lock in profits. In this update, I discuss whether the rally appears sustainable against the backdrop of the 2024 results published in mid-February. The analysis focuses on average contract volumes and rates, signs of potential underinvestment given the surprisingly strong free cash flow, and includes an update on debt and leverage.
CME Group At A New All-Time High - Valuation Concerns Justified?
Positive
Zacks Investment Research
3 days ago
These 2 Finance Stocks Could Beat Earnings: Why They Should Be on Your Radar
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
These 2 Finance Stocks Could Beat Earnings: Why They Should Be on Your Radar
Neutral
CNBC Television
6 days ago
Josh Brown's "Best Stocks in the Market" list update
Josh Brown, CEO of Ritholtz Wealth Management, joins CNBC's "Halftime Report" to give us an update on why he's getting rid of one of the stocks on the list.
Josh Brown's "Best Stocks in the Market" list update
Neutral
PRNewsWire
1 week ago
CME Group to Launch BrokerTec U.S. Treasury Central Limit Order Book in Chicago to Streamline Trading Between Cash and Futures Markets
CHICAGO and LONDON , March 20, 2025 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced that it will launch a second BrokerTec central limit order book (CLOB) for cash U.S. Treasuries in Q3 2025. In an industry-first, the new CLOB will be co-located in Chicago next to CME Group's deeply liquid U.S. Treasury futures and options markets to support trading between cash and derivatives markets.
CME Group to Launch BrokerTec U.S. Treasury Central Limit Order Book in Chicago to Streamline Trading Between Cash and Futures Markets
Positive
Investors Business Daily
1 week ago
CME Stock: How To Use A Bull Put Spread On This Thriving Company
CME stock is thriving and reaching new highs, but here's how to cut risk when investing in the trading marketplace provider. The post CME Stock: How To Use A Bull Put Spread On This Thriving Company appeared first on Investor's Business Daily.
CME Stock: How To Use A Bull Put Spread On This Thriving Company
Negative
Zacks Investment Research
1 week ago
Markets Attempt to Rebound from Correction: Here's What to Do
Fears are lingering in a sign that market participants remain concerned about tariffs and broader economic weakness.
Markets Attempt to Rebound from Correction: Here's What to Do
Positive
Seeking Alpha
1 week ago
Chaos? Bring It On: My Dividend Playbook For This Wild Market
Volatility is back, and while it's normal, fear dominates. Investors are uneasy despite no official correction, as past gains spoiled expectations. Economic uncertainty, rising debt, and inflation risks fuel market anxiety. If Trump acts on lower rates, short-term pain may be inevitable. I'm seizing opportunities, focusing on value and cyclical dividend growth. Buying dips has historically paid off, and I'm betting big on key stocks.
Chaos? Bring It On: My Dividend Playbook For This Wild Market
Neutral
PRNewsWire
1 week ago
CME Group Expands Credit Products with High Yield Duration-Hedged Futures
Volume across credit futures surpasses 275,000 contracts CHICAGO , March 17, 2025 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced the first day of trading in High Yield Duration-Hedged Credit futures, its fourth contract based on Bloomberg corporate bond indexes. The new product enables investors to manage credit exposure with greater precision as demand for fixed income hedging tools continues to grow.
CME Group Expands Credit Products with High Yield Duration-Hedged Futures
Charts implemented using Lightweight Charts™